DE MARTINIS, CAROLA
 Distribuzione geografica
Continente #
NA - Nord America 55
AS - Asia 54
EU - Europa 42
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 156
Nazione #
US - Stati Uniti d'America 49
IT - Italia 29
SG - Singapore 25
CN - Cina 12
VN - Vietnam 8
CA - Canada 4
FI - Finlandia 4
BR - Brasile 3
GB - Regno Unito 3
DE - Germania 2
HK - Hong Kong 2
IN - India 2
AU - Australia 1
BD - Bangladesh 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
MX - Messico 1
NG - Nigeria 1
NL - Olanda 1
PH - Filippine 1
TR - Turchia 1
Totale 156
Città #
San Jose 21
Singapore 15
Council Bluffs 8
New York 7
Ashburn 3
Buttapietra 3
Rome 3
Roverè Veronese 3
Beijing 2
Buffalo 2
Cagliari 2
Helsinki 2
Hong Kong 2
Hải Dương 2
Lappeenranta 2
Montreal 2
Verona 2
Abuja 1
Albignasego 1
Amman 1
Berlin 1
Budapest 1
Bình Phước 1
Cebu City 1
City of London 1
Columbus 1
Da Nang 1
Forest 1
Frankfurt am Main 1
Hanoi 1
Ho Chi Minh City 1
Istanbul 1
Jarinu 1
Jodhpur 1
London 1
Madrid 1
Mexico City 1
Nampa 1
North Bergen 1
Nottingham 1
Olinda 1
Orem 1
Peterborough 1
Rio de Janeiro 1
Riva del Garda 1
Rohtak 1
Sharon 1
Sydney 1
Thessaloniki 1
Tokyo 1
Toronto 1
Trieste 1
Vigonza 1
Totale 117
Nome #
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment 50
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 27
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 26
Editing RUNX2 KO in B16 melanoma cells with Crispr-Cas9 as a potential strategy to enhance in vivo tumor response to therapeutic apporaches 25
EDITING RUNX2 KO IN B16 MELANOMA CELLS WITH CRISPR-CAS9 AS A POTENTIAL STRATEGY TO ENHANCE IN VIVO TUMOR RESPONSE TO THERAPEUTIC APPROACHES 21
Investigating RUNX2 KO in B16 melanoma cells as a potential strategy to enhance in vivo tumor response to therapeutic approaches 19
Totale 168
Categoria #
all - tutte 633
article - articoli 249
book - libri 0
conference - conferenze 384
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026168 0 0 0 0 0 7 18 8 39 79 7 10
Totale 168